|
Aristo Bio-Tech & Lifescience Ltd
|
Registered Office:
E-24,25,26 GIDC,Manjusar Ta. Savli
,
Vadodara
-
391775
,
Gujarat
, India.
Phone :
91-2667-299055/264843 Fax:
Email : cs@aristobiotech.com
Website : www.aristobiotech.com
|
|
Initial public issue of 18,12,800 equity shares of Rs10/- each ("Equity Shares") of Aristo Bio-Tech and Lifescience Limited ("ABLL" or the "Company" or the "Issuer") for cash at a price of Rs72/- per equity share including a share premium of Rs62/- per equity share (the "Issue Price"), aggregating to Rs13.05 crores ("The Issue"), of which 91,200 equity shares of Rs10/- each for cash at a price of Rs72/- per equity share including a share premium of Rs62/- per equity share aggregating to Rs0.66 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less market maker reservation portion i.e. issue of 17,21,600 equity shares of Rs10/- each including a share premium of Rs62/- per equity share aggregating to Rs12.40 crores is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 26.63% and 25.29%, respectively of the post issue paid up equity share capital of the company.
The face value of the equity share is Rs10/- and the issue price is
Rs72/- the issue price is 7.2 times of the face value.
Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter.
|
|
|
|
Opens On
|
Closes On
|
Application
|
Allotment
|
|
|
16-Jan-23
|
19-Jan-23
|
Rs 72.00-0.00
|
Rs 0.00-0.00
|
|
Minimum Application for shares in Nos :1600 Further
Multiples of :1600
|
|
|
|
(Rs Cr)
|
Lead Managers to the Issue
|
|
|
Project Cost
|
11.85
|
| Beeline Capital Advisors Pvt Ltd |
|
|
Project Financed through Current Offer
|
13.05
|
|
|
Post Issue Equity Share Capital
|
6.81
|
|
|
Issue Price
|
Rs 72.00
|
|
|
|